Human MCHR2/GPR145/GPRv17 ORF/cDNA clone-Lentivirus plasmid (NM_032503)

Cat. No.: pGMLP001787
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human MCHR2/GPR145/GPRv17 Lentiviral expression plasmid for MCHR2 lentivirus packaging, MCHR2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.


Target products collection

Go to MCHR2/GPR145 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $586.44
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLP001787
Gene Name MCHR2
Accession Number NM_032503
Gene ID 84539
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 1023 bp
Gene Alias GPR145,GPRv17,MCH-2R,MCH-R2,MCH2,MCH2R,MCHR-2,SLT
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGAATCCATTTCATGCATCTTGTTGGAACACCTCTGCCGAACTTTTAAACAAATCCTGGAATAAAGAGTTTGCTTATCAAACTGCCAGTGTGGTAGATACAGTCATCCTCCCTTCCATGATTGGGATTATCTGTTCAACAGGGCTGGTTGGCAACATCCTCATTGTATTCACTATAATAAGATCCAGGAAAAAAACAGTCCCTGACATCTATATCTGCAACCTGGCTGTGGCTGATTTGGTCCACATAGTTGGAATGCCTTTTCTTATTCACCAATGGGCCCGAGGGGGAGAGTGGGTGTTTGGGGGGCCTCTCTGCACCATCATCACATCCCTGGATACTTGTAACCAATTTGCCTGTAGTGCCATCATGACTGTAATGAGTGTGGACAGGTACTTTGCCCTCGTCCAACCATTTCGACTGACACGTTGGAGAACAAGGTACAAGACCATCCGGATCAATTTGGGCCTTTGGGCAGCTTCCTTTATCCTGGCATTGCCTGTCTGGGTCTACTCGAAGGTCATCAAATTTAAAGACGGTGTTGAGAGTTGTGCTTTTGATTTGACATCCCCTGACGATGTACTCTGGTATACACTTTATTTGACGATAACAACTTTTTTTTTCCCTCTACCCTTGATTTTGGTGTGCTATATTTTAATTTTATGCTATACTTGGGAGATGTATCAACAGAATAAGGATGCCAGATGCTGCAATCCCAGTGTACCAAAACAGAGAGTGATGAAGTTGACAAAGATGGTGCTGGTGCTGGTGGTAGTCTTTATCCTGAGTGCTGCCCCTTATCATGTGATACAACTGGTGAACTTACAGATGGAACAGCCCACACTGGCCTTCTATGTGGGTTATTACCTCTCCATCTGTCTCAGCTATGCCAGCAGCAGCATTAACCCTTTTCTCTACATCCTGCTGAGTGGAAATTTCCAGAAACGTCTGCCTCAAATCCAAAGAAGAGCGACTGAGAAGGAAATCAACAATATGGGAAACACTCTGAAATCACACTTTTAG
ORF Protein Sequence MNPFHASCWNTSAELLNKSWNKEFAYQTASVVDTVILPSMIGIICSTGLVGNILIVFTIIRSRKKTVPDIYICNLAVADLVHIVGMPFLIHQWARGGEWVFGGPLCTIITSLDTCNQFACSAIMTVMSVDRYFALVQPFRLTRWRTRYKTIRINLGLWAASFILALPVWVYSKVIKFKDGVESCAFDLTSPDDVLWYTLYLTITTFFFPLPLILVCYILILCYTWEMYQQNKDARCCNPSVPKQRVMKLTKMVLVLVVVFILSAAPYHVIQLVNLQMEQPTLAFYVGYYLSICLSYASSSINPFLYILLSGNFQKRLPQIQRRATEKEINNMGNTLKSHF

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-T70539-Ab Anti-MCHR2/ GPR145/ GPRv17 monoclonal antibody
    Target Antigen GM-Tg-g-T70539-Ag MCHR2 VLP (virus-like particle)
    ORF Viral Vector pGMLP001787 Human MCHR2 Lentivirus plasmid
    ORF Viral Vector vGMLP001787 Human MCHR2 Lentivirus particle


    Target information

    Target ID GM-T70539
    Target Name MCHR2
    Gene ID 84539, 574369, 101086149, 403562, 782111, 100066146
    Gene Symbol and Synonyms GPR145,GPRv17,MCH-2R,MCH-R2,MCH2,MCH2R,MCHR-2,MCHR2,SLT
    Uniprot Accession Q969V1
    Uniprot Entry Name MCHR2_HUMAN
    Protein Sub-location Transmembrane Protein
    Category Therapeutics Target
    Disease Not Available
    Gene Ensembl ENSG00000152034
    Target Classification GPCR

    Predicted to enable G protein-coupled peptide receptor activity. Predicted to be involved in neuropeptide signaling pathway. Predicted to be located in plasma membrane. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.